Notice
Recent Posts
Recent Comments
| 일 | 월 | 화 | 수 | 목 | 금 | 토 |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 |
Tags
- private equity
- taiwan
- Korea
- Japan
- Korea M&A
- case study
- LOI
- Investment
- LOTTE
- Japan Tobacco
- Malaysia
- securities
- Bank
- OTCBB
- buyout
- acquisition
- China
- Letter of intent
- M&A
- nda
- sk
- Confidential Agreement
- CA
- capital gate
- hong kong
- Acquistion
- Merger
- cgi korea
- PEF
- China Construction Bank
Archives
- Today
- Total
Korea M&A Corporation
American Oriental Bioengineering Completes Guangxi Boke Acquisition
American Oriental Bioengineering, Inc. (NYSE:AOB), a leading manufacturer and distributor of plant-based pharmaceutical and nutraceutical products, announced Thursday that it has completed the acquisition of Guangxi Boke Pharmaceutical Company Limited. The all-cash acquisition, valued at US$36.5 million, was expected by the company to be immediately accretive to earnings. Based in Nanning, Guang..
News/M&A
2007. 10. 22. 11:12